CG Oncology Ownership | Who Owns CG Oncology?

Overview Forecast RevenueFinancials Chart

CG Oncology Ownership Summary

CG Oncology is owned by 110.16% institutional investors, 0.23% insiders. Rtw investments, lp is the largest institutional shareholder, holding 9.04% of CGON shares. Vanguard Health Care Inv is the top mutual fund, with 3.33% of its assets in CG Oncology shares.

CGON Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	CG Oncology	110.16%	0.23%	-10.39%
Sector	Healthcare Stocks	35.58%	11.87%	52.55%
Industry	Biotech Stocks	35.75%	11.83%	52.41%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Rtw investments, lp	6.98M	9.04%	$472.73M
T. rowe price investment management	6.72M	8.69%	$454.84M
Vanguard group	6.54M	8.52%	$271.52M
Decheng capital	6.37M	8.24%	$431.23M
Wellington management group llp	5.37M	6.95%	$363.52M
Blackrock funding, inc. /de	5.06M	6.55%	$342.74M
Fmr	3.76M	4.87%	$254.80M
Tcg crossover management	3.67M	4.75%	$248.40M
Price t rowe associates inc /md/	3.65M	4.73%	$247.23M
State street	2.65M	3.42%	$179.15M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Decheng capital	6.37M	65.21%	$431.23M
Foresite capital management vi	2.22M	32.67%	$150.35M
Foresite capital management v	1.00M	25.08%	$67.95M
Acorn capital advisors	1.13M	21.77%	$76.58M
Tcg crossover management	3.67M	7.11%	$248.40M
Saturn v capital management	579.89K	5.12%	$23.36M
Rtw investments, lp	6.98M	4.70%	$472.73M
Ecor1 capital	1.10M	3.17%	$74.58M
Rosalind advisors	100.00K	2.72%	$6.77M
Stempoint capital lp	205.62K	2.70%	$13.92M

Top Buyers

Holder	Shares	% Assets	Change
T. rowe price investment management	6.72M	0.31%	6.30M
Rtw investments, lp	6.98M	4.70%	4.97M
Driehaus capital management	999.62K	0.50%	999.62K
Farallon capital management	674.00K	0.26%	666.00K
Vanguard fiduciary trust	470.26K	0.01%	470.26K

Top Sellers

Holder	Shares	% Assets	Change
Avidity partners management lp	-	-	-1.47M
Pictet asset management sa	398.00K	0.03%	-951.52K
Kynam capital management, lp	-	-	-945.83K
Braidwell lp	984.78K	2.22%	-885.79K
Deerfield management company, l.p. (series c)	-	-	-850.70K

New Positions

Holder	Shares	% Assets	Change	Value
Driehaus capital management	999.62K	0.50%	999.62K	$67.65M
Vanguard fiduciary trust	470.26K	0.01%	470.26K	$31.83M
Fisher asset management	465.03K	0.01%	465.03K	$31.47M
Adage capital partners gp	399.86K	0.04%	399.86K	$27.06M
Hsbc	187.76K	0.01%	187.76K	$12.71M

Sold Out

Holder	Change
Advisornet financial	-2.00
Stephens consulting	-15.00
Rise advisors	-19.00
Skopos labs	-23.00
Mrp capital investments	-40.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2026	241	18.14%	85,156,871	3.05%	110	0.95%	145	22.88%	62	24.00%
Dec 31, 2025	45	-75.27%	11,870,229	-84.71%	15	0.15%	21	-76.40%	16	-72.88%
Sep 30, 2025	59	-64.88%	10,389,844	-86.31%	13	0.14%	25	-78.63%	20	-28.57%
Jun 30, 2025	167	16.78%	75,899,259	8.77%	99	1.19%	116	31.82%	28	-15.15%
Mar 31, 2025	144	1.41%	70,762,639	10.06%	92	1.01%	88	-7.37%	34	25.93%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Health Care Inv	2.93M	3.33%	-295.38K
Vanguard Total Stock Mkt Idx Inv	2.20M	2.50%	6.26K
Vanguard Small Cap Index	1.58M	1.80%	-3.60K
State Street® SPDR® S&P® Biotech ETF	1.43M	1.62%	-10.13K
iShares Russell 2000 ETF	1.39M	1.58%	11.75K
T. Rowe Price Health Sciences	1.19M	1.35%	83.83K
Vanguard Small Cap Value Index Inv	1.01M	1.15%	6.98K
Fidelity Small Cap Growth	909.86K	1.03%	-
Vanguard Institutional Extnd Mkt Idx Tr	773.16K	0.88%	6.39K
T. Rowe Price Mid-Cap Growth	745.29K	0.85%	745.29K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jun 04, 2026	POST LEONARD E	-	Sell	$54.50K
Apr 17, 2026	Mulay James	-	Sell	$1.14M
Mar 16, 2026	Mulay James	-	Sell	$83.19K
Jan 09, 2026	Mulay James	-	Sell	$28.88K
Jan 09, 2026	Mulay James	-	Sell	$555.92K

Insider Transactions Trends

Date	Buy	Sell
2026 Q2	-	2
2026 Q1	-	3
2025 Q4	-	3
2025 Q3	1	15
2025 Q2	-	2

CGON Ownership FAQ

Who Owns CG Oncology?

CG Oncology shareholders are primarily institutional investors at 110.16%, followed by 0.23% insiders and -10.39% retail investors. The average institutional ownership in CG Oncology's industry, Biotech Stocks , is 35.75%, which CG Oncology exceeds.

Who owns the most shares of CG Oncology?

CG Oncology’s largest shareholders are Rtw investments, lp (6.98M shares, 9.04%), T. rowe price investment management (6.72M shares, 8.69%), and Vanguard group (6.54M shares, 8.52%). Together, they hold 26.25% of CG Oncology’s total shares outstanding.

Does Blackrock own CG Oncology?

BlackRock is not among the top 10 institutional shareholders of CG Oncology.

Who is CG Oncology’s biggest shareholder by percentage of total assets invested?

Decheng capital is CG Oncology’s biggest shareholder by percentage of total assets invested, with 65.21% of its assets in 6.37M CG Oncology shares, valued at 431.23M$.

Who is the top mutual fund holder of CG Oncology shares?

Vanguard Health Care Inv is the top mutual fund holder of CG Oncology shares, with 3.33% of its total shares outstanding invested in 2.93M CG Oncology shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools